Cost, Contracts, and Vendor Oversight: CRO/CDMO Management

Peter Broglie, Associate Director of Program and Process Management at Precision Biosciences, leads a panel examining the critical topics of cost management, contract governance, and CRO/CDMO vendor oversight. As pharma and biotech companies increasingly rely on external partners for clinical operations, manufacturing, and specialized services, the ability to manage these relationships effectively has become a core portfolio management competency.

The panel will address practical challenges including contract structuring for risk-sharing, performance metrics for CRO and CDMO oversight, cost forecasting in the face of clinical trial uncertainty, and strategies for maintaining quality and compliance across outsourced activities. Peter will share lessons learned from managing vendor relationships at Precision Biosciences.

This session is designed for program leaders, procurement professionals, and portfolio managers who want to improve their organization's approach to vendor governance and cost management in drug development.